PUTRAJAYA: The Health Ministry has agreed to grant additional indication approval for the product Evusheld 100mg/ml solution for injection (Tixagevimab 100mg/ml and Cilgavimab 100mg/ml) manufactured by Astrazeneca AB of Sweden.
Health director-general Tan Sri Dr Noor Hisham Abdullah said the approval was made at the 383rd Drug Control Authority (DCA) meeting which convened on Thursday (April 6).
Already a subscriber? Log in.
Unlock 30% Savings on Ad-Free Access Now!
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
